Core Laboratories NV Cash Flow-to-Debt Ratio
Core Laboratories NV cash flow-to-debt ratio. Core Laboratories NV (CLB) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of $3.96 Million could theoretically repay 0% of its total liabilities ($312.58 Million) in one year. Check Core Laboratories NV investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Core Laboratories NV (1995–2025)
Cash flow-to-debt ratio of Core Laboratories NV from 1995 to 2025. Historical debt coverage capacity for Core Laboratories NV across 31 annual periods. Check CLB cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Core Laboratories NV Cash Flow-to-Debt Ratio by Year (1995–2025)
Core Laboratories NV cash flow-to-debt ratio by year from 1995 to 2025. Year-by-year debt coverage analysis for Core Laboratories NV. For the full cash flow conversion analysis, see CLB cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $37.18 Million | $317.19 Million | ▼ -30.9% |
| 2024 | 0.17x | $56.39 Million | $332.67 Million | ▲ +143.8% |
| 2023 | 0.07x | $24.79 Million | $356.59 Million | ▲ +8.5% |
| 2022 | 0.06x | $24.96 Million | $389.40 Million | ▼ -26.4% |
| 2021 | 0.09x | $36.58 Million | $419.85 Million | ▼ -25.8% |
| 2020 | 0.12x | $57.87 Million | $493.01 Million | ▼ -22.3% |
| 2019 | 0.15x | $89.53 Million | $592.53 Million | ▼ -34.1% |
| 2018 | 0.23x | $111.83 Million | $487.93 Million | ▼ -19.6% |
| 2017 | 0.28x | $124.27 Million | $436.08 Million | ▼ -9.7% |
| 2016 | 0.32x | $131.89 Million | $417.75 Million | ▼ -6.5% |
| 2015 | 0.34x | $219.10 Million | $648.96 Million | ▼ -35.3% |
| 2014 | 0.52x | $303.45 Million | $581.66 Million | ▼ -14.0% |
| 2013 | 0.61x | $298.14 Million | $491.62 Million | ▲ +14.7% |
| 2012 | 0.53x | $237.20 Million | $448.60 Million | ▲ +9.7% |
| 2011 | 0.48x | $204.13 Million | $423.48 Million | ▼ -19.5% |
| 2010 | 0.60x | $205.83 Million | $343.70 Million | ▲ +23.9% |
| 2009 | 0.48x | $181.87 Million | $376.41 Million | ▲ +17.5% |
| 2008 | 0.41x | $155.21 Million | $377.34 Million | ▲ +44.4% |
| 2007 | 0.28x | $125.69 Million | $441.16 Million | ▲ +1.3% |
| 2006 | 0.28x | $120.31 Million | $427.93 Million | ▼ -32.6% |
| 2005 | 0.42x | $74.78 Million | $179.28 Million | ▲ +51.9% |
| 2004 | 0.27x | $54.20 Million | $197.43 Million | ▼ -9.9% |
| 2003 | 0.30x | $60.88 Million | $199.92 Million | ▲ +20.9% |
| 2002 | 0.25x | $40.98 Million | $162.66 Million | ▲ +45.1% |
| 2001 | 0.17x | $28.32 Million | $163.08 Million | ▲ +274.8% |
| 2000 | 0.05x | $7.27 Million | $156.86 Million | ▲ +55.4% |
| 1999 | 0.03x | $4.50 Million | $150.90 Million | ▼ -32.0% |
| 1998 | 0.04x | $6.60 Million | $150.50 Million | ▲ +383.2% |
| 1997 | -0.02x | $-1.90 Million | $122.70 Million | ▼ -105.6% |
| 1996 | 0.27x | $8.80 Million | $32.10 Million | ▲ +0.0% |
| 1995 | 0.27x | $7.70 Million | $28.10 Million | — |